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Abstract The CC chemokines RANTES and MIP- I~ are 
known to activate certain leucocytes and leucocytie cell lines. We 
have produced and fully cbaracterised the recombinant proteins 
expressed in E. coil They induce ehemotaxis of the pro-mono- 
c)tic cell line, THP-1 and T cells. THP-1 cells express three of 
the known CC chemokine receptors. In order to study the activa- 
tion of a single receptor, we have expressed the shared receptor 
( (C  CKR-1) for RANTES and MIP - la  stably in the HEK 293 
cell line. We have examined the effects of RANTES and MIP- la  
on the CC CKR-1 transfectants by equilibrium binding studies 
and in a ebemotaxis assay. RANTES competes for pZSlIRAN- 
TES with an ICs0 of 0.6 + 0.23 nM, whereas MIP - la  competes 
for its radiolabelled counterpart with an ICs0 of 10 + 1.6 nM in 
the transfeetants. These affinities are the same as those measured 
on the THP-1 call line. The stably transfected HEK 293 cells 
respond to both these chemokines in the chemotaxis assay with 
the same ECso values as those measured for THP-1 cells. This 
indicates that this cellular response can be mediated through the 
CC CKR-1 receptor. 
K~ T words: Recombinant chemokine; Chemotaxis; RANTES/ 
M IP-I~ receptor; HEK 293 transfectant 
1. Introduction 
The chemokines are a family of pro-inflammatory polypep- 
tides that act on a variety of leucocyte cell types [1,2]. The name 
is derived from their chemoattractant properties (Chemotactic 
cx tokine), but they have also been shown to have more diverse 
eli'ects on leukocytes including calcium mobilisation, histamine 
re,ease, and degranulation. They are all small (8-10 kDa), basic 
proteins and despite a relatively low homology in primary se- 
q~Lence, have a highly conserved four cysteine motif which 
permits their classification i to two sub-groups. The cz chemo- 
kJ aes have an amino acid between the first two Cys residues 
((XC) whereas in the fl subclass the two first Cys residues are 
ati:jacent (CC). In addition, their biological activities can be 
b~oadly separated between the two sub-classes, ince the cz 
chemokines act principally on neutrophils whereas the fl 
chemokines activate the other leucocytes. 
*{ orresponding author. Fax: (41) (22) 794 69 65. 
A',breviations: RANTES, Regulated on Activation, Normal T ex- 
pressed and Secreted; MIP-I~z, macrophage inflammatory protein-In; 
MCP-1, monocyte chemotactic protein-l; IL-8, interleukin-8; IPTG, 
is,~,propylthiogalactoside; ECs0, concentration f agonist giving half the 
maximal response; IC50, concentration f inhibitor giving half the max- 
imal inhibition. 
The chemokines have been shown to mediate their responses 
through G protein coupled seven transmembrane spanning re- 
ceptors. Two receptors have been identified for the ~ chemo- 
kines; IL-8-RA and IL-8-RB [3,4]. IL-8-RA has been shown to 
be specific in that it binds only IL-8 with high affinity, whereas 
IL-8-RB also binds NAP-2 and Gro-~ with high affinity, and 
thus probably mediates the activities on neutrophils induced by 
these two peptides, and their homologue, ENA-78 [5]. The first 
CC chemokine receptor cloned, CC CKR-1 [6,7] was shown to 
be a shared receptor for two members of this sub-class, RAN- 
TES and MIP-I~. Subsequently, a second CC chemokine re- 
ceptor, CC CKR-2, was identified as being a high affinity recep- 
tor for MCP-1 [8]. Recently two new RANTES/MIP<z recep- 
tors have been cloned: CC CKR-3 which is expressed in eosin- 
ophils [9] and CC CKR-4 from a basophilic ell line, KU812 
[10]. 
CC CKR-1 has been demonstrated to transmit activation of 
transfected Xenopus oocytes through calcium mobilisation i - 
duced by both RANTES and MIP-I~z [7]. However, only high 
affinity binding has been described for MIP-I~ whereas the 
affinity reported for RANTES in competition binding studies 
with RANTES has been reported to be very low, in the micro- 
molar range [6]. Yet in THP-1 cells, high affinity binding (500 
picomolar) for RANTES has been demonstrated [11]. 
In order to further characterise the interaction of the two 
ligands RANTES and MIP-lcz, we report the characterisation 
of the recombinant proteins and the CC CKR-1 receptor stably 
expressed in the HEK 293 cell line. 
2. Materials and methods 
2.1. Materials 
Unless otherwise stated, all chemicals were purchased from Sigma 
and were of the highest grade obtainable; nzymes were from Boeringer 
Mannheim and all chromatographic media from Pharmacia. 
[azsI]RANTES and [~25I]MIP-I~ (2200 Ci/mmol) were ither from NEN 
Research Products (Du Pont de Nemours, Brussels, Belgium) or were 
obtained by radiolabelling the recombinant proteins by Amersham 
Laboratories (Amersham, Bucks, UK). The specific activities of the 
[~25I]chemokines labelled by Amersham Laboratories was 2000 Ci/ 
mmol 
2.2. Chemokine cloning and expression 
Human RANTES and MIP-lc~ were cloned from a human bone 
marrow or human peripheral b ood monocyte 2GT11 cDNA libraries 
(Clontech), respectively, by PCR. Briefly, total cDNA inserts in the 
cDNA libraries were first amplified using 2GTll primers which 
flanked the EcoRI cloning site in a 100/11 reaction containing 2/tl of 
phage stock (10 6 plaque-forming units), 10 mM Tris-HC1 buffer, pH 
8.3, 50 mM KCI, 1.5 mM MgCI2, 0.2/zM dNTPs, 2.5 units Amplitaq 
(Perkin Elmer-Cetus) and 1/.tM of each primer (2GT1 IPCR-1 (forward 
primer) 5' GATTGGTGGCGACGACTCCT and 2GTIlPCR-2 
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(reverse primer) 5' CAACTGGTAATGGTAGCGAC) for 30 cycles of 
95°C for 2 min, 55°C for 2 min and 72°C for 5 min in a Techne PHC-2 
thermal cycler. One tenth of the reaction mixture was then subjected 
to a 2nd round of PCR in a 100¢tl reaction ow containing 1¢tM each 
of either RANTES specific primers (forward primer 5' CCATGAAG- 
GTCTCCGCGGCAC reverse primer 5' CCTAGCTCATCTCCAA- 
AGAG antisense) based on the published RANTES cDNA coding 
sequence [12] or MIP-lc~ specific primers [13] (forward primer 5' AT- 
GCAGGTCTCCACTGCTGC and reverse primer 5' TCAGGCACT- 
CAGCTCCAGGTG) for 30 cycles of 95°C for 2 min, 55°C for 2 min 
and 72°C for 5 min. PCR products were visualized on 3% Nu-Sieve 
(FMC) agarose gels stained with 0.5 mg/ml ethidium bromide. Bands 
migrating at the predicted size of RANTES cDNA (278 bp) or MIP-lc~ 
cDNA (279 bp) were gel-purified by standard methods [14]. Gel-puri- 
fied DNA was rendered blunt-ended by sequential treatment with T4 
polynucleotide kinase and E. coli DNA polymerase I Klenow fragment 
(New England Biolabs) and subcloned into the EcoRV site of 
pBluescript II SK-plasmid (Stratagene). Ligation products were elec- 
troporated into electrocompetent E. coli strain XL-I blue using a Bio 
Rad Gene pulser (2.5 kV, 200 W, 25 mF). Following electroporation, 
cells were grown up in LB medium at 37°C for 1 h and then plated on 
LB plates containing 100 mg/ml of ampicillin. Mini-prep DNA pre- 
pared from 3 ml overnight cultures of individual ampicillin resistant 
colonies was digested with restriction enzymes HindIII and EcoRI. 
Mini-prep DNAs which yielded an insert size of approximately 280 bp 
were then subjected to DNA sequence analysis using T3 and T7 primers 
and Sequenase (USB). Sequencing revealed that all clones obtained 
were identical to the published sequence encoding the mature RANTES 
protein or MIP-lc~ protein. Plasmid DNA (1 ,ug) from clone pMIP-I~-2 
was used to generate the mature peptide coding sequence of MIP-lc~ 
by PCR as described above. Clone pRANTES-6 was similarly used to 
generate the mature coding sequence of RANTES, except that the 
forward PCR primer encoded a hexapeptide s quence ending in Arg at 
the 5' end. The resultant PCR products were subcloned into the expres- 
sion vector pT7-7 [15] and transformed into E. coli strain BL21 (DE3). 
T7 RNA polymerase and subsequent MIP-1 c~ or RANTES expression 
was induced by addition of IPTG (isopropylthiogalactoside) to the 
medium. 
2.3. Generation of stable cells' lines expressing CC CKR-1 
A full length cDNA encoding the MIP-I~/RANTES receptor (CC 
CKR-1) was obtained by reverse transcriptase-PCR from the human 
eosinophilic ell line EOL-3 [16] using specific primers based on the 
published sequence [6] and subcloned into the mammalian cell expres- 
sion vector pcDNAI neo (Invitrogen) (C.A. Power and A.J. Hoogewerf, 
unpublished results). CsCI gradient-purified pcDNAlneo/CC CKR-1 
plasmid DNA (30,ug) was transfected into HEK 293 cells by electropo- 
ration using a Bio-Rad Gene Pulser (260 V, 960 mF). Stable transfec- 
tants were selected in DMEM-F12 medium supplemented with 2 mM 
glutamine, 10% foetal calf serum and 600 ¢tg/ml Geneticin (G418, 
Gibco-BRL). G418 resistant clones were individually ring cloned after 
14 days. Clones expressing the receptor were then selected by their 
ability to bind [~25I]M1P-l~ as described above. 
2.4. Recombinant chemokine xpression and purification 
Recombinant MIP-lc~ and RANTES were purified from inclusion 
body pellets by solubilisation i 0.1 M Tris-HC1 buffer, pH 8.0, contain- 
ing 1 mM dithiothreitol and 6 M guanidine HC1 followed by gel filtra- 
tion on a Sephacryl HR $300 column equilibrated in the same buffer. 
The proteins were renatured by a 20-fold dilution into 0.1 M Tris-HCl 
buffer, pH 8.0, containing 1 mM oxidised and 0.1 mM reduced glutathi- 
one and the solution stirred overnight at 4°C. The renatured RANTES 
protein was concentrated by applying the solution to a HiLoad S 
(26110) column equilibrated in 50 mM sodium acetate, pH 4.5, and 
eluting the adsorbed protein with a linear 0.6-2 M NaCI gradient in 
the same buffer. The hexapeptide l ader sequence was removed from 
the fusion protein by incubation in 50 mM Tris-HC1 buffer, pH 8.0, 
with Endoproteinase Arg-C (Boeringer Mannheim) (1:600, en- 
zyme:substrate, w/w) overnight at 37°C. The cleaved product was 
separated by cation exchange chromatography as described above, 
except that 6 M urea was included in the buffers. The renatured MIP-1 c~ 
was concentrated by anion exchange chromatography on a HiLoad 
Q16/10 equilibrated in 20 mM Tris-HC1 buffer, pH 8.0, and eluted with 
a 0 0.5 M NaC1 gradient in the same buffer. The purified proteins 
400 I I I l l l l l  I I i l l i l l l J  I I l J l l l l J  I I l l i l l l J  I I l l i l l l J  I I t  
• • - 
,-.. 300 
._o 
._~ 
.~  200 
o 
E 
E 
• -~ 100 
C) 
0 i ~ 
10 `2 10 "1 10 ° 101 102 103 
[Chemokine] (riM) 
Fig. 1. Mobilisation of intracellular calcium in THP-1 cells by RAN- 
TES and MIP-lm The assay was carried out using 1 x 10 6 cells load- 
ed with Fura-2 dye as described in the text for RANTES (A) and 
MIP-I~ (e). 
were dialysed extensively against firstly 1% acetic acid and finally 0.1% 
trifluoracetic acid and stored as lyophilised powders at -80°C. 
2.5. Analytical methods 
Protein purification and purity were followed by SDS-PAGE using 
4-20% acrylamide mini-gels (Novex) stained with Coomassie Brilliant 
Blue, R250 and reverse phase HPLC carrried out using a Beckman 
System Gold with a VarioPrep NUCLEOSIL 30~7 Cs column 
(259 × 10 ram) (Macherey-Nagel). The purified proteins were quanti- 
fied by the extinction coefficients of A° l~m% = 1.6 for RANTES and 1.28 
for MIP-I~ at 280 nm calculated from the predicted amino acid se- 
quence. Protein sequence was obtained with a model 477A protein 
sequencer (Applied Biosystems) using on line quantification of amino 
acid phenylthiohydantoin derivatives with a Model 120A PTH-amino 
acid analyser. 
2.6. Bioassays 
THP-1 and HEK 293 chemotaxis assays were carried out using 96- 
well micro-Boyden chambers (Neuro-Probe, Cabin John, MD) fitted 
with 5/lm filters for THP- 1 cells and 8/lm filters for the HEK 293 cells. 
The HEK 293 cells were detached from the culture vessels by incubation 
with 5 ml Trypsin-EDTA (1 ×) (Gibco) for 2 min at 37°C, and then 
resuspended at a concentration f 2.8 x 106/ml in D-MEM F 12 medium 
containing 10% FCS, 1 mM (L)-glutamine and 0.06% geneticin sulfate. 
THP-1 cells were resuspended in RPMI 1640 medium containing 0.01 
M HEPES, 10% heat inactivated fetal calf serum (FCS), 2 mM (L)- 
glutamine and 0.005% gentamicin at a concentration of 2.8 x 106/ml. 
Cell suspensions (200/A volume; 5.6 x 105 cells) were placed in the 
upper chamber. Appropriate dilutions of the chemokine in370/A of the 
media described above, but without FCS, were placed in the lower 
chamber. After 60 min incubation at 37°C under 5% CO2, the cells were 
removed from the upper wells, and 200/A PBS containing 20 ¢tM 
EDTA added to detach the cells bound to the filter. After 30 min 
incubation at 4°C, the plate was centrifuged at 1800 x g for 10 min and 
the supernatants removed from the lower wells. The number of cells 
which had migrated were measured by the Cell Titer 96 Non-Radioac- 
tive Cell Proliferation Assay (Promega, Madison, USA) which moni- 
tors the conversion of tetrazolium blue into its formazan product. The 
number of viable cells is obtained from a standard curve relating cell 
number to the absorbance at 590 nm using a Thermomax microtitre 
plate reader (Molecular Devices, Palo Alto, CA). T cell chemotaxis was 
carried out according to [17]. Calcium mobilisation i THP-1 cells was 
carried out according to [18] with the modifications previously de- 
scribed [19]. The data obtained were fitted using Grafit 3.01 software 
[20] to a four-parameter logistic equation. The ECs0 is defined as the 
concentration of agonist giving half the maximal response. 
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FL. 2. Equilibrium competition binding of RANTES and MIP-lc~ to 
T} [P-1 cells. 10 pl of a THP-1 cell suspension in RPM! 1640 medium 
at .~ concentration f2 × l0  7 cells/ml were incubated with 10/A of 1 nM 
[L2 I]RANTES (~,) or [~25I]MIP-I~ (e) and 80 pl of chemokine diluted 
three fold from a 1.25 × 10 -3 M solution in binding buffer for 2 h at 
4°~ ~. The cells were washed four times by filtration under vacuum with 
ict cold binding buffer containing 0.5 M NaC1. Each point represents 
t~ ) experiments. 
2. .  Receptor binding 
Equilibrium competition binding was carried out by incubating 105 
T}IP-1 or HEK 293 cells in 100 ml 50 mM Hepes buffer, pH 7.2, 
co ltaining 1 mM CaCI,, 5 mM MgCI2, 0.5% BSA and 0.002% sodium 
az~de, with 0.4 nM radiolabelled ligand except when indicated other- 
w~e, and varying concentrations of competing ligand. After 2 h incuba- 
ti(,n at 4°C, the cells were washed four times with 1 ml ice cold binding 
buffer containing 0.5 M NaCI by titration on 0.45 pm filters (Millipore) 
ar~d aspiration by vacuum. The filters were suspended in 3.5 ml Ultima 
G,,ld scintillation fluid (Packard) and radioactivity measured on a 
B,.ckman LS5000 counter. The data were fitted using the Grafit 3.01 
so "tware [20] with simple weighting to the equation describing a compe- 
tilon for a single binding site B=Bm,,l{1 +[L]/ICs0} where 
I( ~0 = Kd + [radioligand] [21]. The results are expressed in terms of 
pc,-centage binding in order to compare separate xperiments. 
2. '. Receptor distribution 
Potal RNA was prepared from FACS purified leukocytes and cell 
lix~es using the method of Chomczynski and Sacchi [22]. 10 pg of total 
R'qA (1 mg/ml) and 0.5 ml oligodY~5 (0.5 mg/ml) was heated at 70°C 
fc~ 10 min and then cooled on ice for 2 rain, followed by addition of 
4 nl of 5× 1st strand buffer (250 mM Tris/HC1 buffer, pH 8.3, contain- 
ing 375 mM KCI and 15 mM MgCIz), 2 ml of 0.1 M DTT, 1 ml of 10 
m Vl dNTPs and 1 ml Superscript (Gibco-BRL) for 1 h at 37°C. 2 pl 
al~quots of each reverse transcriptase r action was then subjected to 40 
c.x :les of PCR (95°C for 2 min, 55°C for 2 min and 72°C for 2 min) 
in a 100 ,ul reaction mixture containing 100 pmoles each of specific 
p~mers for CC CKR-I. For THP-1 cells, the following primers were 
aLo used: CC CKR-2-B, IL-8R-B, IL-8R-A, CC CKR-4 and glyceral- 
dchyde-3-phosphate dehydrogenase (GAPDH) as described previously 
[bq. PCR reaction products were analysed on 1% agarose gels. The 
p~ zdicted size of PCR products for the chemokine receptors was ap- 
p~ 3ximately 1.1 kb, and 1.0 kb for GAPDH. 
3. Results 
The chemokines RANTES and MIP-lc~ were expressed at 
wry high levels under control of the T7 RNA polymerase 
sy stem. The final yield of purifed MIP- I~ was 3.85 mg/g E. coli 
cells and that of RANTES,  after the cleavage of the leader 
sequence, was 0.74 mg/g cells. Both proteins were estimated as 
> 98% pure by SDS-PAGE and reverse phase HPLC analyses. 
In order to produce the RANTES protein with the correct 
amino terminus, it was necessary to express the protein with a 
cleavable leader sequence since retention of the initiating 
methionine when the cDNA encoding the mature form of the 
protein is expressed yields an inactive protein [23]). Amino 
terminal sequencing showed that the initiating methionine was 
removed from MIP-I~. 
The recombinant chemokines were tested in two measure- 
ments of cellular activation, chemotaxis and calcium mobilisa- 
tion In the chemotaxis assay using the pro-monocytic cell line, 
THP-1, approximately 2% of the cells in the upper chamber 
migrated randomly in the absence of chemokine. RANTES 
consistently induced the migration of 10 12% of the cells from 
the upper chamber, whereas MIP-lct had less efficacy in this 
assay, inducing the migration of approximately 5% of the cells. 
RANTES had an EC~ value of 0.68 + 0.27 nM, whereas MIP- 
1~ was more potent with an ECs0 value of 0.20 + 0.1 nM. 
Similar values were obtained using commercially available 
chemokines (PeproTech). In a second chemotaxis assay on 
freshly isolated T cells, RANTES had an ECs0 value of 3 nM 
and MIP- I~ 0.11 nM. Both RANTES and MIP- I~ are known 
to mobilise calcium in cells expressing endogenous chemokine 
receptors as well as recombinant receptors. We therefore stab- 
lished a dose response curve for the calcium mobilisation by the 
recombinant chemokines in THP-1 cells. In this assay RAN- 
TES has an 13 nM and MIP- I~ an ECs0 value of 4.7 riM. 
(Fig. 1). 
Transfection of the HEK 293 cells with the cDNA encoding 
the CC CKR-1 receptor was successful as judged by reverse 
transcriptase PCR and Nothern blotting. Since we do not have 
an antibody against he receptor, we judged its integration into 
the membrane by functional assays. Firstly, RANTES was able 
to induce a mobilisation of calcium into the transfected cells, 
but not in un-transfected cells (results not shown). Both 
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Fig. 3. Equilibrium competition binding of radiolabelled RANTES and 
MIP-I~ to HEK 293 cells expressing the recombinant CC CKR-1 
receptor. 105 cells were incubated with 0.4 nM []25I]RANTES (A) or 0.4 
nM []25I]MIP-l~ for 2 h at 4°C in 50 mM Hepes buffer, pH 7.2, 
containing 1mM CaCI2, 5 mM MgC12, 0.5% BSA and 0.002% sodium 
azide. The cells were washed four times by filtration under vacuum with 
ice cold binding buffer containing 0.5 M NaC1. Each point represents 
three experiments. 
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[125I]RANTES and [125I]MIP-lct could bind to the transfected 
cells. Scatchard analysis of saturation binding curves with 
[125I]MIP-l~ showed that the receptor was expressed at 18,000 
sites per cell (results not shown). During initial binding experi- 
ments, we did not observe competition of [1251]RANTES by 
unlabelled RANTES; rather the amount of radioactivity aug- 
mented with increasing concentrations of unlabelled ligand as 
has been previously reported [6]. However, inclusion of 0.5 M 
NaC1 in the wash buffers as described [24] allowed us to observe 
high affinity binding of RANTES to both THP-1 cells and to 
the CC CKR-1 receptor expressed in HEK 293 cells. Competi- 
tion of [J25I]RANTES by unlabelled RANTES resulted in an 
IC50 of 1 nM in THP-1 cells (Fig. 2) and 0.6 nM in HEK 293 
cells expressing the recombinant CC CKR-1 receptor (Fig. 3). 
Competition of [125I]MIP-10~ on THP-1 and HEK 293 cells by 
MIP-lct was achieved with IC50 values of 7.4 and 10 nM, respec- 
tively. To our knowledge, this is the first published emonstra- 
tion of high affinity binding of RANTES to CC CKR-1. 
Complete displacement of the radiolabelled ligands was not 
achieved using concentrations of unlabelled ligand ranging be- 
tween 10-12-10 -6 M routinely used for the experiments o deter- 
mine high affinity binding. At micromolar concentrations of
cold ligand, maximal competition of only 60-80% was achieved 
for MIP-I~ and 30-40% for RANTES. The remaining radiola- 
belled ligand could only be displaced by increasing the concen- 
tration of unlabelled ligand up to millimolar concentrations a
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Fig. 4. Expression of chemokine receptor mRNA. PCR reactions were 
performed on total RNA derived from cells as described in text. One 
tenth of the reaction products were analysed on 1% agarose gels con- 
taining 0.5/tg/ml ethidium bromide. (A) THP-1 cells: Lane 1 = molecu- 
lar mass markers (1 kb ladder, Gibco-BRL); lane 2 = IL-8 receptor A; 
lane 3 = IL-8 receptor B; lane 4 = CC CKR-1; lane 5 = K5-5; lane 
6 = MCP-1 receptor B; lane 7 = GAPDH control. (B) Distribution of 
the CC CKR-1 receptor mRNA in leucocytes and cell lines. 
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Fig. 5. HEK 293 chemotaxis nduced by RANTES and MIP-lct. The 
HEK 293 cells were detached from the culture flasks with 5 ml Trypsin- 
EDTA (1 ×) (Gibco) for 2 min at 37°C, and then resupended at a 
concentration of2.8 x 106/ml in D-MEM F12 medium containing 10% 
FCS, 1 mM L-glutamine and 0.06% geneticin sulfate. The chemotaxis 
assay was carried out as described for THP-1 cells, but using 8/tm 
filters. 
shown in Fig. 2 for THP-1 cells. Scatchard analysis using 
[125i]MiP_ 1 ~ showed that the THP-1 cells had 8200 high affinity 
sites per cell, which is comparable to the number of RANTES 
high affinity sites determined on THP-1 membranes [24]. 
Reverse transcriptase PCR has shown that the CC CKR-1 
receptor is expressed in several leucocytes and cell lines (Fig. 
4a). In addition, the pro-monocytic cell line THP-1 expresses 
several chemokine receptors (Fig 4b). Recently, it has been 
shown that HEK 293 cells transfected with the IL-8 receptor 
undergo chemotaxis in response to this chemokine [25]. We 
therefore xamined the chemotaxis of HEK 293 cells stably 
transfected with the CC CKR-1 receptor in response to RAN- 
TES and MIP-10~. As shown if Fig. 5, the EC50 values measured 
for RANTES, 0.6 nM, and MIP-I~, 0.2 nM, are the same as 
those measured on the THP-1 cell line. Mock transfected HEK 
293 cells do not respond to either chemokine in the same assay, 
so the effect measured can be unequivocably attributed to the 
CC CKR-1 receptor. 
4. Discussion 
In both the in vitro assays tested, chemotaxis of THP- 1 cells 
and freshly isolated T cells, as well as calcium mobilisation i  
THP-1 cells, MIP-I~ is more potent han RANTES. However, 
it has less efficacy in inducing the response. In THP-1 cells the 
chernotactic response induced by RANTES, 11, is more than 
twofold higher than that induced by MIP-I~, which was never 
greater than 5. Similarly, RANTES mobilised 375 nM calcium, 
whereas the maximum mobilised by MIP-lct was 275 nM. 
Both of these chemokines have been shown to activate the 
CC CKR-1 receptor when expressed in HEK 293 cells and 
Xenopus oocytes and induce mobilisation of calcium [6,7]. 
However, only high affinity binding was demonstrated for 
MIP-I~. On the other hand, high affinity binding sites for 
RANTES have been demonstrated on THP-1 cells [24] and on 
butyrate-differentiated HL-60 cells [11]. The affinities reported 
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here as IC50 values can be translated to the affinity binding 
constant, by the equation IC50 = [L*] + [Kd] where [L*] is the 
concentration of radioligand [21]. Thus MIP-I~ has a Kd of 7 
nM for THP-1 cells and 9.6 nM for the HEK 293 cells express- 
ing the CC CKR-1 receptor, whereas RANTES has a Kd of 600 
pM for THP-1 cells and 200 pM for the CC CKR-1 receptor 
expressed in HEK 293 cells. The CC CKR-1 receptor is there- 
fo,'e probably the high affinity binding site observed for RAN- 
TES in the THP-1 and HL-60 cell lines, both of which express 
trmscripts for the receptor [7]. 
The in vitro chemotaxis assay using the recombinantly ex- 
pJ zssing HEK 293 cells indicates that the CC CKR-1 receptor 
ce :tainly functions as a mediator of chemotaxis. The ECs0 val- 
ues for the induction by both chemokines of chemotaxis are 
identical for THP-1 cells and that mediated by the recombinant 
C2 CKR-1 receptor. Although it was first reported that T cells 
d ,  not have the transcript for this receptor [7], we have been 
atle to show the contrary. It is therefore possible that this 
re-eptor also mediates chemotaxis in lymphocytes. 
We therefore conclude that RANTES binds 10-50 fold more 
ti::htly than MIP-I~ to their shared receptor, CC CKR-1. How- 
ex er, MIP-I~ is more potent in inducing biological responses, 
a~ least in vitro. 
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